Vir Biotechnology, Inc. (VIR)
11.08
+0.36
(+3.41%)
USD |
NASDAQ |
Aug 26, 16:00
11.08
0.00 (0.00%)
After-Hours: 16:02
Vir Biotechnology Max Drawdown (5Y) : 94.85% for July 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| July 31, 2026 | 94.85% |
| June 30, 2026 | 94.85% |
| May 31, 2026 | 94.85% |
| April 30, 2026 | 94.85% |
| March 31, 2026 | 94.85% |
| February 28, 2026 | 94.85% |
| January 31, 2026 | 94.85% |
| December 31, 2025 | 94.85% |
| November 30, 2025 | 94.85% |
| October 31, 2025 | 94.85% |
| September 30, 2025 | 94.85% |
| August 31, 2025 | 94.85% |
| July 31, 2025 | 94.58% |
| June 30, 2025 | 94.58% |
| May 31, 2025 | 94.58% |
| April 30, 2025 | 93.75% |
| March 31, 2025 | 92.20% |
| February 28, 2025 | 91.89% |
| January 31, 2025 | 91.89% |
| December 31, 2024 | 91.89% |
| November 30, 2024 | 91.89% |
| October 31, 2024 | 91.26% |
| September 30, 2024 | 91.26% |
| August 31, 2024 | 90.82% |
| July 31, 2024 | 90.82% |
| Date | Value |
|---|---|
| June 30, 2024 | 90.82% |
| May 31, 2024 | 90.82% |
| April 30, 2024 | 90.82% |
| March 31, 2024 | 90.66% |
| February 29, 2024 | 90.66% |
| January 31, 2024 | 90.66% |
| December 31, 2023 | 90.66% |
| November 30, 2023 | 90.66% |
| October 31, 2023 | 90.66% |
| September 30, 2023 | 89.00% |
| August 31, 2023 | 85.22% |
| July 31, 2023 | 84.71% |
| June 30, 2023 | 78.02% |
| May 31, 2023 | 78.02% |
| April 30, 2023 | 78.02% |
| March 31, 2023 | 78.02% |
| February 28, 2023 | 78.02% |
| January 31, 2023 | 78.02% |
| December 31, 2022 | 78.02% |
| November 30, 2022 | 78.02% |
| October 31, 2022 | 78.02% |
| September 30, 2022 | 78.02% |
| August 31, 2022 | 77.03% |
| July 31, 2022 | 77.03% |
| June 30, 2022 | 77.03% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Caribou Biosciences, Inc. | 97.58% |
| Arrowhead Pharmaceuticals, Inc. | 88.96% |
| Oncolytics Biotech, Inc. | 92.83% |
| Sangamo Therapeutics, Inc. | 99.68% |
| Sarepta Therapeutics, Inc. | 93.33% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -43.58 |
| Beta (5Y) | 1.660 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 62.35% |
| Historical Sharpe Ratio (5Y) | -0.454 |
| Historical Sortino (5Y) | -0.838 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 27.02% |